Product Description
Empagliflozin is used to treat type 2 diabetes. It works in the kidneys to prevent absorption of glucose (blood sugar). This helps lower the blood sugar level. Empagliflozin does not help patients who have insulin-dependent or type 1 diabetes.Effective Glycemic Control for AdultsEmpagliflozin Tablets offer a reliable solution for adults with type 2 diabetes aiming to improve glycemic control. Acting as a SGLT2 inhibitor, this medication helps the kidneys remove excess glucose from the bloodstream, thereby lowering blood sugar levels. Its efficacy makes it a vital part of many diabetes management plans.
Quality Assurance and Safe AdministrationManufactured in India under strict WHO-GMP and ISO 9001:2015 standards, Empagliflozin Tablets are produced under rigorous quality control measures. Oral administration allows for straightforward daily dosing, whether taken with or without food, all while prioritizing patient safety and effective results.
Practical Packaging and StorageEmpagliflozin Tablets are typically supplied in packs of 10x10 strips or boxes, making them suitable for various distribution needs. For best quality, tablets should be stored below 30C, protected from moisture and light, ensuring a shelf life of up to 24 to 36 months from the manufacturing date.
FAQ's of Empagliflozin Tablet:
Q: How should Empagliflozin Tablets be taken for optimal effectiveness?
A: Empagliflozin Tablets should be taken once daily, as prescribed by your physician, and can be administered with or without food. Always follow your healthcare provider's specific dosage instructions for best results.
Q: What are the primary benefits of using Empagliflozin for type 2 diabetes?
A: Empagliflozin helps lower blood glucose levels by enabling the kidneys to remove excess sugar via urine. This contributes to better glycemic control, which may reduce the risk of diabetes-related complications when combined with diet and exercise.
Q: When is Empagliflozin not recommended for use?
A: Empagliflozin should not be used for type 1 diabetes or in cases of diabetic ketoacidosis. It is intended only for adults diagnosed with type 2 diabetes and must be used strictly under medical supervision.
Q: Where are Empagliflozin Tablets manufactured and who markets them?
A: These tablets are manufactured in India at WHO-GMP/ISO 9001:2015 certified facilities and are distributed globally by various pharmaceutical companies. The exact brand and manufacturer details can be found on the product packaging.
Q: What processes are followed to ensure the quality of Empagliflozin Tablets?
A: Empagliflozin Tablets are produced following international pharmaceutical standards, including WHO-GMP and ISO certifications. Quality control measures from raw material sourcing through packaging and export are strictly observed to ensure product efficacy and safety.
Q: What are some possible side effects or precautions associated with Empagliflozin?
A: Common side effects can include increased urination, urinary tract infections, and dehydration. Patients should avoid this medication if they have type 1 diabetes or a history of diabetic ketoacidosis and should consult a physician if adverse effects occur.
Q: How should Empagliflozin Tablets be stored to maintain their effectiveness?
A: Keep the tablets below 30C and protect them from moisture and light. Ensure they remain in their original packaging until use, and do not use the product past its expiration date as indicated on the box.